Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac in acute submassive pulmonary embolism
2012-000247-27Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pulmonary embolism (PE) comparing Diclofenac with Placebo (2 arms). Primary endpoint: Right ventricular dysfunction at 36-48 hours. Started Jan 2012; status: completed.
02
Drugs
diclofenac
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2012-000247-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000247-27.